Suppliers / Horizon Therapeutics Ireland Dac

Horizon Therapeutics Ireland Dac

Ireland Updated 9 July 2026

Horizon Therapeutics Ireland Dac is a finished-dose manufacturer based in Ireland. It appears in 28 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, EMA and NMPA (CN).

0
active US DMFs
0
valid CEPs
0
registered plants
28
filings across 3 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 24 None
EMA 3 None
NMPA (CN) 1 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Horizon Therapeutics Ireland Dac

Does Horizon Therapeutics Ireland Dac hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Horizon Therapeutics Ireland Dac. It does have 28 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Horizon Therapeutics Ireland Dac file?
Filings are on record with Health Canada, EMA and NMPA (CN), 28 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Horizon Therapeutics Ireland Dac comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability